Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Fernanda
Contact Fernanda, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Preemptive Rituximab for Epstein-Barr Virus Reactivation after Hematopoietic Cell Transplantation: Necessary for All?
1 Introduction Epstein–Barr virus (EBV)-related post-transplant lymphoproliferative disorder (PTLD) is a significant cause of morbidity and mortality in hematopoietic cell transplant (HCT) recipients. The risk of EBV-PTLD is primarily associated with the degree of T-cell depletion. Well-recognized pre-transplant risk factors include donor/recipient EBV serology mismatch, cord blood transplantation (CBT), HLA mismatch, second HCT, and the use of anti-thymocyte globulin (ATG) or alemtuzumab.
Compliance with yellow fever and measles vaccines in the revaccination program post‐hematopoietic cell transplantation
Abstract Introduction Measles, mumps, rubella, and even poliomyelitis outbreaks have recently perplexed infectious disease clinicians and epidemiologists globally due to the decline in vaccination coverage rates in children and adults. Measles and yellow fever (YF) have represented an increasing burden on the Brazilian public health system in recent decades.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Fernanda
Contact Fernanda, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack